The latest lymphoma news
ASH 2022: CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of…
Browsing: Lymphoma
FDA approves brentuximab vedotin in combination with chemotherapy for paediatric patients with classical Hodgkin lymphoma
The Food and Drug Administration approved brentuximab vedotin in combination with doxorubicin, vincristine, etoposide, prednisone, and…
Zanubrutinib receives European commission approval for the treatment of adults with marginal zone lymphoma
European Commission (EC) has granted marketing authorization of zanubrutinib for the treatment of adult patients…
People with early-stage Hodgkin lymphoma face a higher risk of dying from cardiovascular disease than from cancer
Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer…
‘Goldilocks’ treatment window could lead to cancer therapy without harmful side-effects
Researchers have developed a way to potentially reduce the toxic side-effects of a type of…
EHA 2022: Ibrutinib combination with bendamustine-rituximab and rituximab maintenance as a first-line treatment for older patients with mantle cell lymphoma significantly improves PFS
Mantle cell lymphoma (MCL) is an aggressive type of non-Hodgkin lymphoma that develops from B…
ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma
Ibrutinib (Imbruvica) combined with bendamustine-rituximab improved progression-free survival by 50% for older patients with newly…
Study reveals cause, potential precision therapies for aggressive type of lymphoma
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells…
Early study finds new lymphoma drug effective
In early research led by the University of Michigan Health Rogel Cancer Center, USA, the…
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida…